comparemela.com

Sagamihara National Hospital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Motohiro Ebisawa, MD, PhD: Phase 3 Findings on Neffy for Pediatric Patients At-Risk of Anaphylaxis

In this interview, Ebisawa discusses his team’s recent research into the frequently-discussed non-injector epinephrine alternative neffy.

Omalizumab eases extra-respiratory symptoms in aspirin-exacerbated respiratory disease

The extra-respiratory symptoms of aspirin-exacerbated respiratory disease improved with omalizumab at baseline and during aspirin challenges, according to a study published in The Journal of Allergy & Clinical Immunology. This treatment may enable patients to reduce or eliminate their use of corticosteroids in treating these symptoms, Hiroaki Hayashi, MD, PhD, Clinical Research Center for

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.